Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidney Goldstein

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|August 7, 2007
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failureValerio Zacà, Sharad Rastogi, Makoto Imai, et al.
European Journal of Heart Failure|February 27, 2004
Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogsHideaki Morita, George Suzuki, Walid Haddad, et al.
Cardiology|October 4, 2008
Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failureValerio Zacà, Sharad Rastogi, Sudhish Mishra, et al.
Cardiovascular Drugs and Therapy|October 11, 2002
Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failureTakayuki Mishima, Mitsuhiro Tanimura, George Suzuki, et al.
Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.
Journal of Cardiac Failure|March 4, 2003
Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failureHideaki Morita, George Suzuki, Walid Haddad, et al.
Journal of the American College of Cardiology|April 3, 2007
Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trialsCamille G Frazier, Karen P Alexander, L Kristin Newby, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 24, 2006
Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureHideaki Morita, Sanjaya Khanal, Sharad Rastogi, et al.
Cardiovascular Drugs and Therapy|March 26, 2003
Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureHideaki Morita, George Suzuki, Takayuki Mishima, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 22, 2005
The COMET trialMichael R Bristow, Kirkwood F Adams, Jerry L Bauman, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|August 7, 2007
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failureValerio Zacà, Sharad Rastogi, Makoto Imai, et al.
European Journal of Heart Failure|February 27, 2004
Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogsHideaki Morita, George Suzuki, Walid Haddad, et al.
Cardiology|October 4, 2008
Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failureValerio Zacà, Sharad Rastogi, Sudhish Mishra, et al.
Cardiovascular Drugs and Therapy|October 11, 2002
Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failureTakayuki Mishima, Mitsuhiro Tanimura, George Suzuki, et al.
Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.
Journal of Cardiac Failure|March 4, 2003
Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failureHideaki Morita, George Suzuki, Walid Haddad, et al.
Journal of the American College of Cardiology|April 3, 2007
Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trialsCamille G Frazier, Karen P Alexander, L Kristin Newby, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 24, 2006
Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureHideaki Morita, Sanjaya Khanal, Sharad Rastogi, et al.
Cardiovascular Drugs and Therapy|March 26, 2003
Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failureHideaki Morita, George Suzuki, Takayuki Mishima, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 22, 2005
The COMET trialMichael R Bristow, Kirkwood F Adams, Jerry L Bauman, et al.
Pageof 5